Microbiological contamination in counterfeit and unapproved drugs

201427 citationsJournal Articlegold Open Access

Authors

Dieter Pullirsch

Julie Bellemare · Inuit Tapiriit Kanatami

Andreas Hackl · Austrian Agency for Health and Food Safety

Yvon-Louis Trottier · Health Canada

A. Mayrhofer · Austrian Agency for Health and Food Safety

Heidemarie Schindl · Austrian Agency for Health and Food Safety

Christine Taillon · Inuit Tapiriit Kanatami

Abstract

Our results show that counterfeit and unapproved pharmaceuticals are not manufactured under the same hygienic conditions as legitimate products. The microbiological contamination of illegal medicinal products often exceeds USP and EP limits, representing a potential threat to consumer health.

Topics & Keywords

Pharmaceutical Quality and Counterfeiting Pharmaceutical Economics and Policy Pharmaceutical and Antibiotic Environmental Impacts

Publication Details

Published in: BMC Pharmacology and Toxicology

Volume 15, Issue 1, pp. 34-34

DOI: 10.1186/2050-6511-15-34

Field-Weighted Citation Impact: 2.25

Command Palette

Microbiological contamination in counterfeit and unapproved drugs

Authors

Abstract

Topics & Keywords

Publication Details